Hide Studies Not Open or Pending
Condition(s):Relapsed and/or Refractory Multiple MyelomaLast Updated:April 4, 2019Unknown status
Condition(s):Multiple MyelomaLast Updated:November 12, 2019Approved for marketing
Condition(s):Multiple MyelomaLast Updated:November 17, 2016Completed
Condition(s):Multiple MyelomaLast Updated:August 24, 2016Completed
Condition(s):Multiple Myeloma, RefractoryLast Updated:January 31, 2023Recruiting
Condition(s):Relapsed and/or refractorY Multiple MyelomaLast Updated:February 20, 2020Completed
Condition(s):Refractory Multiple Myeloma; Relapsed Multiple MyelomaLast Updated:June 2, 2022Completed
Condition(s):Relapsed/Refractory Multiple Myeloma; Relapsed/Refractory Diffuse Large B-Cell LymphomaLast Updated:January 13, 2023Recruiting
Condition(s):Relapsed Multiple Myeloma; Refractory Multiple MyelomaLast Updated:September 23, 2022Completed
Condition(s):Relapse/Refractory Multiple MyelomaLast Updated:November 30, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.